IPO registrations (S-1, F-1) · Registrants
AVEDRO INC
- SEC CIK
- 1343304 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2019-01-18, last 2019-02-04; 1 initial registration, 1 amendment
- Outcome
- Final prospectus filed 2019-02-14; declared effective 2019-02-13
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 201 JONES ROAD, Waltham, MA 02451
- EDGAR entity type
- operating
- Insiders and CEO pay
- AVEDRO INC on the corporate pages
Offering terms
- Proposed price range
- $14.00–$16.00 per share (S-1/A filed 2019-02-04)
- Final price
- $14.00 per share, within the range (424B4 filed 2019-02-14, an initial public offering)
- Shares sold
- 5,000,000
- Gross proceeds
- $70,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol AVDR
- Lead underwriters
- Merrill Lynch; J.P. Morgan (1,600,000 shares)
- Syndicate
- BofA Securities; Cowen (600,000); Guggenheim Securities (600,000); Leerink Partners (600,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Avedro, Inc Fuzzy (name and state)
- Business registration: AVEDRO INC Fuzzy (name and state)
- Federal award recipient: AVEDRO, INC. Fuzzy (name and state)
- Form D issuer: AVEDRO INC EXACT (CIK (EXACT))
- Lobbying client: AVEDRO, INC. Fuzzy (name and state)
- SEC filer: AVEDRO INC EXACT (CIK (EXACT))
Filings 4
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2019-01-18 | S-1 | S-1 (registration) | AVEDRO INC | 0001193125-19-012969 ↗ |
| 2019-02-04 | S-1/A | S-1/A (amendment) | AVEDRO INC | 0001193125-19-026369 ↗ |
| 2019-02-13 | EFFECT | EFFECT (declared effective) | AVEDRO INC | 9999999995-19-000232 ↗ |
| 2019-02-14 | 424B4 | 424B4 (final prospectus) | AVEDRO INC | 0001193125-19-040772 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-02-04 | S-1/A | registration statement | $14.00–$16.00 | 5,000,000 | - | Nasdaq AVDR | 6 | primary document; range, shares headline, cover names 5 | document ↗ | |
| 2019-02-14 | 424B4 | final prospectus | $14.00 | 5,000,000 | $70,000,000 | Nasdaq AVDR | 6 | primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 5 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Bavier Paul S | Officer | General Counsel and Sec. | 5 | 2019 | |
| Burns Thomas William | Director | 3 | 2019 | ||
| Desai Keval | TenPercentOwner | 3 | 2019 | ||
| First David | Officer | Chief Human Resources Officer | 5 | 2019 | |
| GRIFFIN THOMAS E | Officer | Chief Financial Officer | 6 | 2019 | |
| HealthQuest Partners II, L.P. | TenPercentOwner | 1 | 2019 | ||
| HealthQuest Venture Management II, L.L.C. | TenPercentOwner | 1 | 2019 | ||
| InterWest Management Partners X, LLC | TenPercentOwner | 3 | 2019 | ||
| INTERWEST PARTNERS X LP | TenPercentOwner | 3 | 2019 | ||
| Kliman Gilbert H | Director,TenPercentOwner; TenPercentOwner | 4 | 2019 | ||
| Kong Garheng | Director; Director,TenPercentOwner | 4 | 2019 | ||
| Lu Hongbo | Director | 4 | 2019 | ||
| NASR KHALED | TenPercentOwner | 3 | 2019 | ||
| ORBIMED ADVISORS LLC | TenPercentOwner | 2 | 2019 | ||
| OrbiMed Capital GP VI LLC | TenPercentOwner | 2 | 2019 | ||
| Orbimed ROF II LLC | TenPercentOwner | 2 | 2019 | ||
| ORONSKY ARNOLD L | TenPercentOwner | 3 | 2019 | ||
| PALMISANO ROBERT J | Director | 4 | 2019 | ||
| Rajpal Rajesh K. | Officer | Chief Medical Officer | 9 | 2019 | |
| Schuermann James | Officer | Chief Business Officer | 5 | 2019 | |
| SILVERSTEIN JONATHAN | Director,TenPercentOwner | 4 | 2019 | ||
| Zadno Reza | Director,Officer | President and CEO | 7 | 2019 | |
| Zurbay Donald | Director | 4 | 2019 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2018-05-11 | AVEDRO INC | Other Health Care | $24,999,971 | $24,999,971 | 19 | 1 |
| 2017-05-01 | AVEDRO INC | Other Health Care | $12,000,003 | $12,000,003 | 14 | 1 |
| 2015-11-25 | AVEDRO INC | Other Health Care | $32,000,000 | $16,533,010 | 23 | 1 |
| 2014-11-19 | AVEDRO INC | Other Health Care | $17,555,000 | $13,693,602 | 22 | 2 |
| 2012-02-17 | AVEDRO INC | Other Health Care | $26,031,735 | $26,031,735 | 23 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | AVEDRO INC | MA | Form D private offerings | CIK (EXACT) |
| SEC filer | AVEDRO INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Business registration | Avedro, Inc | State business registries | name and state | |
| Business registration | AVEDRO INC | State business registries | name and state | |
| Federal award recipient | AVEDRO, INC. | Federal spending (USAspending) | name and state | |
| Lobbying client | AVEDRO, INC. | Federal lobbying (LDA) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.